EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
about
Epigenetics in liver disease: from biology to therapeuticsEpigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1.Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.Methylation-mediated silencing of microRNA-211 promotes cell growth and epithelial to mesenchymal transition through activation of the AKT/β-catenin pathway in GBMDurable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamideDecrease of miR-622 expression suppresses migration and invasion by targeting regulation of DYRK2 in colorectal cancer cellsEffects of miR-338 on morphine tolerance by targeting CXCR4 in a rat model of bone cancer pain.Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis.CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia.Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets.Epigenetic reprogramming in liver fibrosis and cancer.MicroRNA-622 suppresses the proliferation of glioma cells by targeting YAP1.Hypoxia and hyperoxia differentially control proliferation of rat neural crest stem cells via distinct regulatory pathways of the HIF1α-CXCR4 and TP53-TPM1 proteins.A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis.MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein.The suppressing role of miR-622 in renal cell carcinoma progression by down-regulation of CCL18/MAPK signal pathway.miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.AFF4 promotes tumorigenesis and tumor-initiation capacity of head and neck squamous cell carcinoma cells by regulating SOX2.
P2860
Q28079271-10EF2FF5-FA38-4A20-B8C9-297443769A24Q30008860-9D9018B2-2E08-4832-AB3D-B55D4165F77BQ30843748-AFDF6836-1FEC-4D9D-AA28-1AB8947E7C86Q33648797-FA8D5E14-C63E-4324-86A3-73D05C6831BDQ37136281-871CC9D6-A126-4679-BC27-AF3883B67B9BQ37669901-DAD4D36F-9454-424D-8EAF-8F9D11653C9AQ37700237-F03F7AAC-D245-4295-945A-181015D648E9Q38974653-ADC7CE77-F0C3-4E99-8753-30E7EE551850Q40443884-D4FCFEFF-BD43-467A-A9C1-B51FB0A6114AQ47135284-549ACAA5-730B-4230-8F1D-0EF0E15D5874Q47157566-E60AECB6-2F4C-4E2B-98F1-1A20AF6F3870Q47969122-709A2D6E-872A-4994-8E76-2C04DA487A61Q50467900-7801BB2E-2DE7-473B-A7D6-97301435AD3CQ51015312-38111E47-73BC-405E-939C-6555E615BD8DQ51180526-9695AD6D-44B4-4188-AB60-922160BC7817Q52672936-C23A866F-5C79-4EC2-A0E6-CCDBC00156A6Q54947450-E2EA32C1-6C52-4E17-965E-955C6CA88FB2Q54978475-42CBBAD4-5A2E-43A6-B2E2-E712A6699739Q55514429-B13908A9-B935-44D3-BA97-DFC31EBB3494
P2860
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
@ast
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
@en
type
label
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
@ast
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
@en
prefLabel
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
@ast
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma.
@en
P2093
Weijuan Zhang
Yidong Liu
P2860
P2888
P356
10.1038/NCOMMS9494
P407
P577
2015-09-25T00:00:00Z